Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 EPS of ($1.00), $0.03 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Worried the AI trade has gone too far? Evercore likes these 4 stocks